Compare SNAP & CRL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | SNAP | CRL |
|---|---|---|
| Founded | 2010 | 1947 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Computer Software: Programming Data Processing | Biotechnology: Commercial Physical & Biological Resarch |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 10.3B | 8.6B |
| IPO Year | 2017 | 1999 |
| Metric | SNAP | CRL |
|---|---|---|
| Price | $5.61 | $155.71 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 26 | 12 |
| Target Price | $8.41 | ★ $198.27 |
| AVG Volume (30 Days) | ★ 37.2M | 769.9K |
| Earning Date | 05-06-2026 | 05-07-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 35.71 | N/A |
| EPS | ★ N/A | N/A |
| Revenue | $824,949,000.00 | ★ $1,857,601,000.00 |
| Revenue This Year | $15.55 | N/A |
| Revenue Next Year | $9.82 | $3.04 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ 103.95 | 10.48 |
| 52 Week Low | $3.81 | $132.58 |
| 52 Week High | $10.41 | $228.88 |
| Indicator | SNAP | CRL |
|---|---|---|
| Relative Strength Index (RSI) | 49.28 | 39.85 |
| Support Level | $5.46 | $147.22 |
| Resistance Level | $7.62 | $184.75 |
| Average True Range (ATR) | 0.33 | 8.76 |
| MACD | -0.08 | -2.44 |
| Stochastic Oscillator | 37.02 | 20.29 |
Snap is a technology company best known for its marquis social media application. Snapchat, a visual messaging application that has amassed hundreds of millions of users. The app was initially only used to communicate with family and friends through photographs and short videos (known as "Snaps"). Users can now enjoy augmented reality, or AR, lenses, content from famous creators and celebrities, updates about local events, and more. Although the app offers a paid subscription option with premium features, advertising sales produce most of the app's revenue. The firm also sells wearable devices called AR Spectacles, which can capture photos and videos overlayed with AR lenses, but these make up a small portion of Snap's overall sales.
Charles River Laboratories was founded in 1947 and is a leading provider of drug discovery and development services. The company's research model & services segment is the leading provider of animal models for laboratory testing, which breeds and delivers animal research models with specific genetic characteristics for preclinical studies around the world. The discovery & safety assessment segment includes services required to take a drug through the early development process, including discovery services. The manufacturing support segment includes microbial solutions, which provides in vitro (non-animal) testing products, biologics testing services, and avian vaccine services.